Drug General Information (ID: D1149)
  Drug Name
Nitrous oxide
  Drug Type Small molecule
  Drug Synonymous
Distickstoffmonoxid; Lachgas; Stickdioxyd; Dinitrogen monoxide; Dinitrogen oxide; Factitious air; Gaz hilarant; Hyponitrous acid anhydride; Laughing gas; Nitrogen hypoxide; Nitrogenium oxydulatum; Nitrous oxide [JAN]; Oxido nitroso; Oxido nitroso [Spanish]; Oxyde nitreux; Stickdioxyd [German]; N2O; Nitrous oxide [UN1070] [Nonflammable gas]; Diazyne 1-oxide; Gas, Laughing; NITROUS-OXIDE; Nitrogen oxide (N2O); Nitrous oxide (TN); Nitrous oxide [Anaesthetics, volatile]; Nitrous oxide, compressed; Nitrous oxide, refrigerated liquid; Nitrous oxide, refrigerated liquid [UN2201] [Nonflammable gas]; Oxide, Nitrous; Protoxyde d'azote; Protoxyde d'azote [French]; Nitrous oxide (JP15/USP); Oxidodinitrogen(N-N); Stickstoff(I)-oxid
    Click to Show/Hide
  Disease Class 6B00-6B0Z: Anxiety disorder
  Therapeutic Class Respiratory Agents
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula N2O
  InChI 1S/N2O/c1-2-3
  InChIKey GQPLMRYTRLFLPF-UHFFFAOYSA-N
  Canonical SMILES [N-]=[N+]=O
  External Link
Pubchem ID 948
CAS Number 10024-97-2
CHEBI ID 17045
TTD ID D0O8DI

Drug-Drug Interaction Network
  Sunburst Graph
AM006  Pharmacodynamic additive effects
BM036  Additive cardiorespiratory depression effects
BM038  Additive CNS depression effects
BM042  Additive hypotensive effects
BM045  Additive neuromuscular blocking effects
BM109  Increased risk of other adverse reactions (Unspecific)
  Relation Graph
 Full list of drugs interacting with Nitrous oxide
      Pharmacodynamic additive effects
   Additive cardiorespiratory depression effects Drug Num:  24
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0035
 
Alfentanil
 
C21H32N6O3
 
51263 
Moderate    Inter Info   
[9], [10], [11]
D0219
 
Buprenorphine
 
C29H41NO4
 
644073 
Moderate    Inter Info   
[9], [10], [11]
D0226
 
Butorphanol
 
C21H29NO2
 
5361092 
Moderate    Inter Info   
[9], [10], [11]
D0379
 
Codeine
 
C18H21NO3
 
5284371 
Moderate    Inter Info   
[9], [10], [11]
D0467
 
Dextropropoxyphene
 
C22H29NO2
 
10100 
Moderate    Inter Info   
[9], [10], [11]
D0470
 
Dezocine
 
C16H23NO
 
3033053 
Moderate    Inter Info   
[9], [10], [11]
D0471
 
Diamorphine
 
C21H23NO5
 
5462328 
Moderate    Inter Info   
[9], [10], [11]
D0493
 
Dihydrocodeine
 
C18H23NO3
 
5284543 
Moderate    Inter Info   
[9], [10], [11]
D0646
 
Fentanyl
 
C22H28N2O
 
3345 
Moderate    Inter Info   
[9], [10], [11]
D0772
 
Hydrocodone
 
C18H21NO3
 
5284569 
Moderate    Inter Info   
[9], [10], [11]
D0776
 
Hydromorphone
 
C17H19NO3
 
5284570 
Moderate    Inter Info   
[9], [10], [11]
D0909
 
Levacetylmethadol
 
C23H31NO2
 
15130 
Moderate    Inter Info   
[9], [10], [11]
D0923
 
Levorphanol
 
C17H23NO
 
5359272 
Moderate    Inter Info   
[9], [10], [11]
D1001
 
Meperidine
 
C15H21NO2
 
4058 
Moderate    Inter Info   
[9], [10], [11]
D1017
 
Methadone
 
C21H27NO
 
4095 
Moderate    Inter Info   
[9], [10], [11]
D1089
 
Morphine
 
C17H19NO3
 
5288826 
Moderate    Inter Info   
[9], [10], [11]
D1100
 
Nalbuphine
 
C21H27NO4
 
5311304 
Moderate    Inter Info   
[9], [10], [11]
D0161
 
Benzhydrocodone
 
C25H25NO4
 
49836084 
Moderate    Inter Info   
[9], [10], [11]
D1169
 
Oliceridine
 
C22H30N2O2S
 
66553195 
Moderate    Inter Info   
[9], [10], [11]
D1183
 
Opium
 
NA
 
NA
Moderate    Inter Info   
[9], [10], [11]
D1203
 
Oxycodone
 
C18H21NO4
 
5284603 
Moderate    Inter Info   
[9], [10], [11]
D1208
 
Oxymorphone
 
C17H19NO4
 
5284604 
Moderate    Inter Info   
[9], [10], [11]
D1247
 
Pentazocine
 
C19H27NO
 
441278 
Moderate    Inter Info   
[9], [10], [11]
D1390
 
Remifentanil
 
C20H28N2O5
 
60815 
Moderate    Inter Info   
[9], [10], [11]
   Additive CNS depression effects Drug Num:  1
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1485
 
Sodium oxybate
 
C4H7NaO3
 
23663870 
Major    Inter Info   
[7], [8]
   Additive hypotensive effects Drug Num:  2
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0444
 
Deserpidine
 
C32H38N2O8
 
8550 
Moderate    Inter Info   
[18], [19]
D1393
 
Reserpine
 
C33H40N2O9
 
5770 
Moderate    Inter Info   
[18], [19]
   Additive neuromuscular blocking effects Drug Num:  12
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0343
 
Cisatracurium
 
C53H72N2O12+2
 
62887 
Moderate    Inter Info   
[15], [16], [17]
D0522
 
Doxacurium
 
C56H78N2O16+2
 
60169 
Moderate    Inter Info   
[15], [16], [17]
D1047
 
Metocurine
 
C40H48N2O6+2
 
21233 
Moderate    Inter Info   
[15], [16], [17]
D1080
 
Mivacurium
 
C58H80N2O14+2
 
5281042 
Moderate    Inter Info   
[15], [16], [17]
D0122
 
Atracurium
 
C53H72N2O12+2
 
47319 
Moderate    Inter Info   
[15], [16], [17]
D1219
 
Pancuronium
 
C35H60N2O4+2
 
441289 
Moderate    Inter Info   
[15], [16], [17]
D1295
 
Pipecuronium
 
C35H62N4O4+2
 
50192 
Moderate    Inter Info   
[15], [16], [17]
D1384
 
Rapacuronium
 
C37H61N2O4+
 
5311399 
Moderate    Inter Info   
[15], [16], [17]
D1420
 
Rocuronium
 
C32H53N2O4+
 
441290 
Moderate    Inter Info   
[15], [16], [17]
D1510
 
Succinylcholine
 
C14H30N2O4+2
 
5314 
Moderate    Inter Info   
[15], [16], [17]
D1659
 
Tubocurarine
 
C37H41N2O6+
 
6000 
Moderate    Inter Info   
[15], [16], [17]
D1684
 
Vecuronium
 
C34H57N2O4+
 
39765 
Moderate    Inter Info   
[15], [16], [17]
   Increased risk of other adverse reactions (Unspecific) Drug Num:  6
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0853
 
Isocarboxazid
 
C12H13N3O2
 
3759 
Major    Inter Info   
[1], [2], [3]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Major    Inter Info   
[4], [5], [6]
D1263
 
Phenelzine
 
C8H12N2
 
3675 
Major    Inter Info   
[1], [2], [3]
D1455
 
Selegiline
 
C13H17N
 
26757 
Major    Inter Info   
[1], [2], [3]
D1620
 
Tranylcypromine
 
C9H11N
 
19493 
Major    Inter Info   
[1], [2], [3]
D0143
 
Baclofen
 
C10H12ClNO2
 
2284 
Moderate    Inter Info   
[12], [13], [14]
References
1 Product Information. Azilect (rasagiline). Teva Pharmaceuticals USA, North Wales, PA.
2 Product Information. Marplan (isocarboxazid) Roche Laboratories, Nutley, NJ.
3 Product Information. Nardil (phenelzine). Parke-Dvis, Morris Plains, NJ.
4 Canadian Pharmacists Association "e-CPS."
5 Goldhirsch A, Gelber RD, Tattersall MN, Rudenstam CM "Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer." Lancet ii (1987): 151.[PMID: 2885607]
6 Ermens AA, Schoester M, Spijkers LJ, Lindemans J, Abels J "Toxicity of methotrexate in rats preexposed to nitrous oxide." Cancer Res 49 (1989): 6337-41.[PMID: 2804978]
7 Product Information. Xywav (calcium/magnesium/potass/sodium oxybates). Jazz Pharmaceuticals, Palo Alto, CA.
8 Product Information. Xyrem (sodium oxybate). Orphan Medical, Minnetonka, MN.
9 Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
10 Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
11 Inagaki Y, Kuzukawa A "Effects of epidural and intravenous buprenorphine on halothane minimum alveolar anesthetic concentration and hemodynamic responses." Anesth Analg 84 (1997): 100-5
12 Cerner Multum, Inc. "Australian Product Information.".
13 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
14 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
15 Kronenfeld MA, Thomas SJ, Turndorf H "Recurrence of neuromuscular blockade after reversal of vecuronium in a patient receiving polymyxin/amikacin sternal irrigation." Anesthesiology 65 (1986): 93-4. [PMID: 2873764]
16 Mirakhur RK, Ferres CJ, Clarke RS, Bali IM, Dundee JW. Clinical evaluation of Org NC 45. Br J Anaesth. 1983 Feb;55(2):119-24.
17 Withington DE, Donati F, Bevan DR, Varin F "Potentiation of atracurium neuromuscular blockade by enflurane: time-course of effect." Anesth Analg 72 (1991): 469-73
18 Ziegler CH, Lovette JB "Operative complications after therapy with reserpine and reserpine compounds." JAMA 176 (1961): 114-7
19 Jahr JS, Weber S "Ventricular dysrhythmias following an alfentanil anesthetic in a patient on reserpine for hypertension." Acta Anaesthesiol Scand 35 (1991): 788-9